These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date Terminated 2004-003700-38 Einfluß einer supplementären Therapie mit postprandial injiziertem Insulin Lispro (Huma-log®) auf diabetesbezogene Komplikationen und Lebensqualität bei geriatrischen Patienten mit Typ 2 Diabetes bad-data
Reported results 2011-002986-39 A Phase IIa, Double-Blind, Placebo-Controlled, Randomised, Fourfold Cross-Over Study to Investigate the Glucose Lowering Effects of Dextromethorphan and Amantadine in Subjects with Type 2 Diabetes Mel... 2012-05-23 due-trials
Reported results 2012-004300-35 Effects of Linagliptin on Endothelial- , Renal-, and Retinal Function in Comparison to Placebo in Patients with Hypertension and Albuminuria Wirkung von Linagliptin auf Endothel-, Renal- und Retina... 2014-09-30 due-trials
Reported results 2013-000364-28 Effects of Linagliptin on active GLP-1 concentrations in subjects with renal impairment 2016-04-22 due-trials
Reported results 2013-003171-35 A bicentric open-label, randomized, two-parallel-group study investigating the impact of combined Lantus®(insulin glargine) and Lyxumia ®(lixisenatide) on insulin secretion and gastric emptying in sub... 2014-10-28 due-trials
Reported results 2013-003356-21 A phase IIa, dose-finding, double-blind, placebo-controlled, double-dummy, randomized, eightfold cross-over study to investigate the glucose lowering effects of dextromethorphan alone or in combinatio... 2014-04-01 due-trials
Reported results 2014-003144-12 A trial to compare the pharmacokinetics and pharmacodynamics of insulin lispro administered s.c. into lipohypertrophic or normal abdominal adipose tissue in subjects with diabetes mellitus type 1 2014-11-25 due-trials
Reported results 2014-003788-39 Effect of Saxagliptin in Addition to Dapagliflozin and Metformin on Insulin Resistance, Islet Cell Dysfunction, and Metabolic Control in Subjects with Type 2 Diabetes Mellitus on Previous Metformin Tr... 2016-08-15 due-trials
Reported results 2014-004895-48 Effects of Linagliptin in Addition to Empagliflozin on Islet Cell Physiology and Metabolic Control in Patients with Type 2 Diabetes Mellitus on Stable Metformin Treatment 2015-12-10 due-trials
Completed, but no date, and reported results 2016-004480-39 DPP-4 inhibition with sitagliptin and the risk for hypoglycaemia in the fasting state in subjects with type 2 diabetes treated to fasting plasma glucose targets with insulin glargine and metformin bad-data
Reported results 2017-002175-25 Effects on blood pressure and central sympathetic nerve traffic by SGLT2-inhibition with empagliflozin compared to hydrochlorothiazide in patients with type 2 diabetes mellitus 2020-04-20 due-trials